NeuroVive secures NeuroSTAT FDA fast track designation for TBI
NeuroSTAT FDA fast track designation : Swedish mitochondrial medicine company NeuroVive Pharmaceutical has secured Fast Track designation from the US
The post NeuroVive secures NeuroSTAT FDA fast track designation for TBI appeared first on PharmaNewsDaily.com.
Italian pharma company Zambon acquires Breath Therapeutics for €140m
Zambon acquisition of Breath Therapeutics : Italian pharma company Zambon has acquired German biopharma company Breath Therapeutics and its subsidiaries
The post Italian pharma company Zambon acquires Breath Therapeutics for €140m appeared first on PharmaNewsDaily.com.
Aptar wins FDA approval for Unidose Powder System for nasal spray of hypoglycemia drug
AptarGroup (Aptar) said that its Unidose Powder System has been approved by the US Food and Drug Administration (FDA) for
The post Aptar wins FDA approval for Unidose Powder System for nasal spray of hypoglycemia drug appeared first on PharmaNewsDaily.com.
Six foods that can prevent stroke – Foods which protects brain
Proteostasis begins dosing in phase 2 cystic fibrosis trial
Boston-based biopharma company Proteostasis Therapeutics has dosed the first patient in a phase 2 clinical trial of its cystic fibrosis
The post Proteostasis begins dosing in phase 2 cystic fibrosis trial appeared first on PharmaNewsDaily.com.
Lilly secures Baqsimi FDA approval for severe hypoglycemia
Baqsimi FDA approval : Eli Lilly and Company (Lilly) has secured the US Food and Drug Administration (FDA) approval) for
The post Lilly secures Baqsimi FDA approval for severe hypoglycemia appeared first on PharmaNewsDaily.com.
Ligand acquires antigen-discovery company Ab Initio Biotherapeutics
Ligand acquisition of Ab Initio : US biopharma company Ligand Pharmaceuticals has acquired California-based antigen-discovery company Ab Initio Biotherapeutics for
The post Ligand acquires antigen-discovery company Ab Initio Biotherapeutics appeared first on PharmaNewsDaily.com.
La Jolla secures FDA orphan status for malaria candidate LJPC-0118
La Jolla Pharmaceutical’s LJPC-0118 (artesunate) has been granted orphan drug designation from the US Food and Drug Administration (FDA) for
The post La Jolla secures FDA orphan status for malaria candidate LJPC-0118 appeared first on PharmaNewsDaily.com.
Apic Bio bags FDA orphan designation for ALS SOD1 gene therapy APB-102
US gene therapy company Apic Bio said that APB-102, its ALS SOD1 gene therapy, has been granted orphan drug designation
The post Apic Bio bags FDA orphan designation for ALS SOD1 gene therapy APB-102 appeared first on PharmaNewsDaily.com.
Baxter secures Myxredlin FDA approval for insulin IV infusion
Myxredlin FDA approval : US health care company Baxter International has secured approval from the US Food and Drug Administration
The post Baxter secures Myxredlin FDA approval for insulin IV infusion appeared first on PharmaNewsDaily.com.